Nepstar

NPD) ( "Nepstar" or "the Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the third quarter ended September 30, 2009.

StreetInsider.com News Articles 2009

NPD) ( "Nepstar" or "the Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the third quarter ended September 30, 2009.

unknown title 2009

Previously, Mr. Chen was chief financial officer of China Nepstar Chain Drug Store Ltd., helping lead the Chinese pharmacy chain's initial public offering.

Canadian Solar Finance Chief Departs Following SEC Inquiry Matt Jarzemsky 2010

Nepstar, a subsidiary of Chinese health-care conglomerate Neptunus Group, ran more than 2,000 drugstores in 62 Chinese cities as of the end of last year.

China's Health-Care Overhaul 2008

China Nepstar Chain Drugstore sold 20.6 million American depositary shares, also at a price above its expected $11.50 to $13.50 price range, which was set by underwriters Goldman Sachs Group Inc. and Merrill Lynch

IPOs Find Going Tough 2007

A live web cast of the conference call will be available on the Nepstar website at 11:59 p.m.

unknown title 2011

(NYSE: NPD - News) ("China Nepstar" or the "Company"), the largest drugstore chain in China based on the number of directly operated stores, announced today that the company will report its second quarter fiscal year 2011 financial results on Tuesday, August 23, 2011 before the market opens.

unknown title 2011

Nepstar uses directly operated stores, centralized procurement and a network of distribution centers to provide its customers with high-quality, professional and convenient pharmacy services and a wide variety of other merchandise, including OTC drugs, nutritional supplements, herbal products, personal care products, family care products, and convenience products including consumables.

unknown title 2011

Nepstar's strategy of centralized procurement, competitive pricing, customer loyalty programs and private label offerings has enabled it to capitalize on the robust economic growth in China and to take advantage of the demographic trend in China Nepstar Chain Drugstore to Report Second Quarter 2011 Financial Results on August 23

unknown title 2011

While pharmaceutical companies such as American Oriental Bioengineering (NYSE: AOB) are betting that hospitals will remain important purchasing points for consumers, for example, companies such as China Nepstar (NYSE: NPD) have been suggesting that the government will revise regulations to give retail drug stores an important new presence in the market.

Fool.com Headlines Tim Hanson 2010